Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Ticker
SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 10,965 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 87,597 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Legal Officer gave up 36,032 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Scientific Officer gave up 45,797 shares (to pay taxes)
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Grant or award Chief Accounting Officer acquired 6,903 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 37,358 shares (grant or award)
  11. 4 Grant or award Chief Legal Officer acquired 26,897 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 33,622 shares (grant or award)
  13. 4 Grant or award Chief Commercial Officer acquired 31,380 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 79,976 shares (grant or award)
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 4 Grant or award Director acquired 3,722 shares (grant or award)
  17. 4 Grant or award Director acquired 5,955 shares (grant or award)
  18. 4 Grant or award Director acquired 3,722 shares (grant or award)
  19. 4 Grant or award Director acquired 3,722 shares (grant or award)
  20. 4 Grant or award Director acquired 3,722 shares (grant or award)

Page 5 of 29 · 572 filings